Guselkumab Provides Long-Term Relief in Psoriatic Arthritis ...Middle East

Medscape - News
More than 90% of patients with PsA who received guselkumab every 8 weeks in the DISCOVER-2 trial maintained minimal clinically important improvement in joint symptoms through week 52. Medscape Medical News

Hence then, the article about guselkumab provides long term relief in psoriatic arthritis was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Guselkumab Provides Long-Term Relief in Psoriatic Arthritis )

Apple Storegoogle play

Last updated :

Also on site :



Latest News